Skip to content

EPRX

Eupraxia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$8.58
+2.39%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 3, 2026
EPS estimate
-$0.27
Revenue estimate

Latest reported

Last report date
Aug 11, 2026
EPS actual
-$0.23
EPS estimate
-$0.25
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
-9.3%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 11, 2026-$0.25-$0.23Beat 8.00%
May 12, 2026-$0.22-$0.23Miss -4.55%
Aug 12, 2025-$0.21-$0.26Miss -23.81%
Mar 20, 2025-$0.18-$0.21Miss -16.67%
Nov 7, 2024-$0.13-$0.17Miss -30.05%
Mar 21, 2024-$0.15$3.0M
Sep 29, 2022-$0.31-$0.22Beat 29.96%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026